Holding(s) in Company

RNS Number : 1723X
Dechra Pharmaceuticals PLC
10 August 2009
 






TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES


1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

  Dechra Pharmaceuticals


2 Reason for the notification (please tick the appropriate box or boxes):


An acquisition or disposal of voting rights


An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 


An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 


An event changing the breakdown of voting rights

 


Other (please specify):

  

 


3. Full name of person(s) subject to the notification obligation:


 Schroders plc

4. Full name of shareholder(s) (if different from 3.):


 

5. Date of the transaction and date on which the threshold is crossed or reached:


 07.08.09

6. Date on which issuer notified:


 10.08.09

7. Threshold(s) that is/are crossed or reached:


 15% - 16%

  

8. Notified details:

A: Voting rights attached to shares


Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the 
triggering
transaction

Resulting situation after the triggering transaction

Number
of

Shares

Number
of

V
oting
Rights

Number
of shares

Number of voting
rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

 Ordinary

 13,319,102

10,454,094 

13,544,102 

N/A 

10,679,094 

N/A 

16.28% 

 GB0009633180


B: Qualifying Financial Instruments

Resulting situation after the triggering transaction


Type of financial
instrument

Expiration
date

Exercise/ 
Conversion 
Period

Number of voting
rights that may be

acquired if the

instrument is

exercised/ converted.


% of voting
rights

 

 

 

 

 


C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction


Type of financial
instrument

Exercise 
price

Expiration 
date

Exercise/
Conversion 

period

Number of voting 
rights instrument 
refers to

% of voting rights


 

 

 

 

 

Nominal

Delta


 

 


Total (A+B+C)


Number of voting rights

Percentage of voting rights

 10,679,094

 16.28%


9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:

 

SCHRODER INVESTMENT MANAGEMENT LIMITED              10,173,594      15.51%

SCHRODER INVESTMENT MANAGEMENT NORTH 
AMERICA LIMITED                                                                          505,500       0.77%

 


Proxy Voting:


10. Name of the proxy holder:


 

11. Number of voting rights proxy holder will cease to hold:


 

12. Date on which proxy holder will cease to hold voting rights:


 


13. Additional information:


This shares referred to in section 9 are held in portfolios managed by those firms on a discretionary basis for clients under investment management agreements.

 

14. Contact name:


 Taryn O'Donoghue

15. Contact telephone number:


 020 7658 6000



This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLDGGMRZGVGLZM
UK 100

Latest directors dealings